Cargando…

Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy

Approximately 820 women die in pregnancy and childbirth every day worldwide, with 99% of these occurring in low-resource settings. The most common causes of maternal mortality are haemorrhage, sepsis and hypertensive disorders. There are established, effective solutions to these complications, howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Vousden, Nicola, Nathan, Hannah L., Shennan, Andrew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020004/
https://www.ncbi.nlm.nih.gov/pubmed/29945641
http://dx.doi.org/10.1186/s12978-018-0533-4
_version_ 1783335222255812608
author Vousden, Nicola
Nathan, Hannah L.
Shennan, Andrew H.
author_facet Vousden, Nicola
Nathan, Hannah L.
Shennan, Andrew H.
author_sort Vousden, Nicola
collection PubMed
description Approximately 820 women die in pregnancy and childbirth every day worldwide, with 99% of these occurring in low-resource settings. The most common causes of maternal mortality are haemorrhage, sepsis and hypertensive disorders. There are established, effective solutions to these complications, however challenges remain in identifying who is at greatest risk and ensuring that interventions are delivered early when they have the greatest potential to benefit. Measuring vital signs is the first step in identifying women at risk. Overstretched or poorly trained staff and inadequate access to accurate, reliable equipment to measure vital signs can potentially result in delayed treatment initiation. Early warning systems may help alert users to identify patients at risk, especially where novel technologies can improve usability by automating calculations and alerting users to abnormalities. This may be of greatest benefit in under-resourced settings where task-sharing is common and early identification of complications can allow for prioritisation of life-saving interventions. This paper highlights the challenges of accurate vital sign measurement in pregnancy and identifies innovations which may improve detection of pregnancy complications.
format Online
Article
Text
id pubmed-6020004
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60200042018-07-06 Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy Vousden, Nicola Nathan, Hannah L. Shennan, Andrew H. Reprod Health Commentary Approximately 820 women die in pregnancy and childbirth every day worldwide, with 99% of these occurring in low-resource settings. The most common causes of maternal mortality are haemorrhage, sepsis and hypertensive disorders. There are established, effective solutions to these complications, however challenges remain in identifying who is at greatest risk and ensuring that interventions are delivered early when they have the greatest potential to benefit. Measuring vital signs is the first step in identifying women at risk. Overstretched or poorly trained staff and inadequate access to accurate, reliable equipment to measure vital signs can potentially result in delayed treatment initiation. Early warning systems may help alert users to identify patients at risk, especially where novel technologies can improve usability by automating calculations and alerting users to abnormalities. This may be of greatest benefit in under-resourced settings where task-sharing is common and early identification of complications can allow for prioritisation of life-saving interventions. This paper highlights the challenges of accurate vital sign measurement in pregnancy and identifies innovations which may improve detection of pregnancy complications. BioMed Central 2018-06-22 /pmc/articles/PMC6020004/ /pubmed/29945641 http://dx.doi.org/10.1186/s12978-018-0533-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Vousden, Nicola
Nathan, Hannah L.
Shennan, Andrew H.
Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy
title Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy
title_full Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy
title_fullStr Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy
title_full_unstemmed Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy
title_short Innovations in vital signs measurement for the detection of hypertension and shock in pregnancy
title_sort innovations in vital signs measurement for the detection of hypertension and shock in pregnancy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020004/
https://www.ncbi.nlm.nih.gov/pubmed/29945641
http://dx.doi.org/10.1186/s12978-018-0533-4
work_keys_str_mv AT vousdennicola innovationsinvitalsignsmeasurementforthedetectionofhypertensionandshockinpregnancy
AT nathanhannahl innovationsinvitalsignsmeasurementforthedetectionofhypertensionandshockinpregnancy
AT shennanandrewh innovationsinvitalsignsmeasurementforthedetectionofhypertensionandshockinpregnancy